Search
for
Sort by
Research 61–90 of 1000+
- Exploring pericyte and cardiac stem cell secretome unveils new tactics for drug discovery
- Female sexuality and common sexual dysfunctions: evaluation and management in a primary care setting
- Finasteride-Induced Inhibition of 5α-Reductase Type 2 Could Lead to Kidney Damage—Animal, Experimental Study
- Ottawa, Ontario, Canada, February 13–16, 2013
- Abstracts
- Atlas of Geriatric Dermatology
- ANIFROLUMAB IN THE MANAGEMENT OF LUPUS HEADACHES: A CASE REPORT
- Anorexia Nervosa and Bulimia Nervosa
- Lipid nanocarriers as innovative strategies for hair regrowth
- ASSOCIATION OF SYSTEMIC LUPUS ERYTHEMATOSUS AND CHRONIC GRANULOMATOUS DISEASE IN ADULTS: REPORT OF 2 CASES
- THERAPEUTIC CHALLENGES IN POLYAUTOIMMUNITY: ANIFROLUMAB FOR LUPUS ERYTHEMATODES IN OVERLAPPING AUTOIMMUNE SYNDROMES
- MIXED CONNECTIVE TISSUE DISEASE EVOLVING FROM THE SEQUENTIAL OVERLAP OF SYSTEMIC LUPUS ERYTHEMATOSUS, SJÖGREN’S SYNDROME, RHEUMATOID ARTHRITIS AND DERMATOMYOSITIS: A FOLLOW-UP
- Changes in the level of sex hormones with aging and their influence on the voice
- Capillaroscopic patterns in patients with systemic sclerosis, psoriasis and alopecia and their correlations with serum concentrations of several angiogenic markers
- Drugs that affect autonomic functions or the extrapyramidal system
- National scientific medical meeting 1996 abstracts
- Cytostatics and immunosuppressive drugs
- Neural Mechanisms of Hair Growth Control
- Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management
- Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder?
- The Clinical Presentation of Systemic Lupus Erythematosus
- Fibroblast heterogeneity and tertiary lymphoid tissues in the kidney
- Health Care-Related Economic Burden of the Polycystic Ovary Syndrome during the Reproductive Life Span
- Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
- Metabolic risk in PCOS: phenotype and adiposity impact
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- Ovarian Hypertension: Polycystic Ovary Syndrome
- Targets to treat androgen excess in polycystic ovary syndrome
- Protective cardiovascular and renal actions of vitamin D and estrogen
- Medical consequences of long-term anabolic-androgenic Steroids (AASs) abuses in athletes